Immunic, Inc.
IMUX
$0.65
$0.00-0.31%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.63% | -5.29% | -1.18% | -3.31% | -13.98% |
| Total Depreciation and Amortization | -6.98% | 0.00% | 22.86% | -16.67% | 35.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 87.41% | -6.73% | -0.52% | 6.42% | 26.94% |
| Change in Net Operating Assets | 711.68% | -86.27% | 2,095.77% | -95.43% | -43.58% |
| Cash from Operations | 18.16% | -13.01% | 5.17% | -10.43% | -22.04% |
| Capital Expenditure | -86.11% | 23.40% | -1,466.67% | 94.00% | 72.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -86.11% | 23.40% | -1,466.67% | 94.00% | 72.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -78.20% | -71.02% | 189.30% | -335.78% | 155.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -149.21% | 291.94% | 8.71% | -13.46% | -17.11% |